How many Covidien hernia mesh cases are pending?

The Judicial Panel on Multidistrict Litigation's September 1, 2026 report lists 2,453 actions pending in federal MDL 3029 in the District of Massachusetts. Counting state courts, Medtronic's quarterly filing says about 10,500 plaintiffs had sued the company and its subsidiaries over hernia mesh as of August 5, 2026, including about 7,450 in a coordinated Massachusetts state court proceeding and about 500 in Minnesota state court.

What happened in the first Covidien hernia mesh bellwether trial?

Patterson v. Covidien went to trial on July 13, 2026 before Judge Patti B. Saris. On August 4, 2026, the jury returned a verdict for the plaintiffs, and on August 7 the court entered judgment of $77 million for Larry Patterson and $11 million for his wife, Tammy Patterson, for a total of $88 million. Post-trial motions filed on September 4, 2026 were still pending in late September, and Medtronic has said it will appeal if necessary.

When is the next Covidien hernia mesh bellwether trial?

Judge Saris set the second bellwether, Stephen v. Covidien, for a jury trial on January 11, 2027, with a final pretrial conference on December 10, 2026. A ProGrip bellwether, Passmore v. Covidien, is set for trial on March 29, 2027.

Is there a Covidien hernia mesh settlement?

No global settlement had been announced as of late September 2026. Medtronic's September 2026 quarterly filing says it has not recorded a liability for the Patterson verdict because it plans to challenge it, and the MDL docket shows the court scheduling more bellwether trials into 2027.

Who qualifies for a Covidien hernia mesh lawsuit?

Typical claims involve implantation of a Covidien mesh product such as Symbotex, Parietex, or ProGrip, followed by complications including adhesions, bowel obstruction, hernia recurrence, or revision/explant surgery.

What medical records are needed for Covidien mesh cases?

Operative reports and implant stickers from the original repair, imaging, revision/explant operative notes, pathology if available, specialist follow-up, and billing records that identify the product and complication timeline.

What is a firm's exposure if a Covidien plaintiff fact sheet is filed with incomplete records?

Product identification is the load-bearing element in MDL 3029, because Covidien and Bard are separate defendants with separate product lines and a firm carrying mixed mesh inventory has to prove which manufacturer's device was implanted. A fact sheet that asserts a Covidien product without an operative report, implant sticker, or purchase record supporting it is exposed to a dismissal motion on the pleadings and, at minimum, to being passed over in any workup pool. Curing that after a deadline is materially harder than sourcing it during intake.

What records must a firm produce to support product identification on a mesh claim?

The operative report from the original repair is the primary document, but it does not always name the device. Where it does not, the implant sticker or device log from the hospital, the facility's billing or supply record for the procedure, and the pathology report from an explant are the practical fallbacks. Firms working mesh inventory should treat product identification as a separate retrieval target rather than assuming the operative report will carry it, since a missing product name can strand an otherwise viable claim.

How long does it take a firm to assemble a complete records package for MDL 3029?

A mesh claimant typically has an implanting facility, a complication treater, a revision or explant surgeon, and imaging, and those are often different institutions. Manual retrieval across that set runs into weeks per claimant once follow-up and re-request cycles are counted. Through an outsourced retrieval partner, records come back in 4 days on average with roughly 30-40% returned same day, which moves the constraint from turnaround to knowing the full provider list up front.

Covidien Hernia Mesh Lawsuit Update 2026: $88M Verdict

Covidien Hernia Mesh Lawsuit Update 2026: Jury Awards $88 Million in First Bellwether, Second Trial Set for January 2027

A federal jury in Boston returned an $88 million verdict against Medtronic's Covidien unit on August 4, 2026, in the first bellwether trial of the Covidien hernia mesh multidistrict litigation. Judge Patti B. Saris entered judgment on August 7 for $77 million to Larry Patterson and $11 million to his wife, Tammy Patterson. The case, Patterson v. Covidien, had opened on July 13, 2026 in the U.S. District Court for the District of Massachusetts.

The verdict does not bind other plaintiffs, but it is the first jury result in a docket of 2,453 pending federal actions, according to the Judicial Panel on Multidistrict Litigation's September 1, 2026 report. Post-trial motions are pending, and Judge Saris has set the second bellwether trial for January 11, 2027.

$88M

Patterson verdict, August 4, 2026 ($77M plus $11M loss of consortium)

2,453cases

Actions pending in MDL 3029 (JPML report, September 1, 2026)

10,500

Approximate hernia mesh plaintiffs suing Medtronic in all courts (Medtronic 10-Q, August 2026)

What the Patterson jury decided

Patterson, an Alabama man, alleged that a Symbotex composite mesh implanted during a 2017 hernia repair adhered to his bowel and caused a bowel obstruction and hernia recurrence that required another operation in 2020. He brought his claims under Alabama law, according to the court's April 28, 2026 opinion. Closing arguments and deliberations began July 30, and the jury returned its verdict on August 4, the 16th day of trial, per the court docket.

According to MassDevice's review of the verdict, the jury found that Covidien failed to give an adequate warning and that the missing warning caused Patterson significant harm. It also found that Covidien made false or misleading statements about Symbotex without intending to and concealed an important fact about the mesh. The jury sided with Medtronic and Covidien on the claim that the company intentionally or recklessly made false statements. AboutLawsuits reported that the full award was compensatory and that the jury did not award punitive damages.

At trial, the Pattersons argued that the porcine collagen coating on Symbotex was known to break down faster than bovine collagen and that Medtronic did not warn surgeons about that risk. Medtronic's lawyers argued that the implant worked as designed, that it did not cause the obstruction, and that the hernia recurrence and factors such as obesity and diabetes explained his complications, MassDevice reported, citing Reuters.

Important

Medtronic plans to challenge the verdict

In its quarterly report filed September 3, 2026, Medtronic said the verdict and award are inconsistent with the law and the trial evidence and that it will appeal if necessary. The company has not recorded a liability for the verdict because it considers a loss not probable at this time.

That position comes from Medtronic's Form 10-Q for the quarter ended July 31, 2026. The Patterson docket shows motions for judgment as a matter of law, for a new trial, and to alter or amend the judgment filed on September 4, 2026, with no ruling entered as of September 29.

Case background and timeline

Covidien mesh products, including Symbotex, Parietex, and ProGrip, face product liability claims alleging adhesions, organ perforation, chronic pain, bowel obstruction, and hernia recurrence requiring revision surgery. Federal cases were centralized as MDL 3029, In re: Covidien Hernia Mesh Products Liability Litigation (No. II), before Judge Saris in the District of Massachusetts in June 2022.

The federal MDL is only part of the exposure. Medtronic's 10-Q says that as of August 5, 2026, about 10,500 individual plaintiffs had sued the company and its subsidiaries over hernia mesh. About 7,450 of them are in a coordinated proceeding in Massachusetts state court, about 500 are in a coordinated action in Minnesota state court, and about 2,400 are in the federal MDL.

June 2022: MDL created

JPML centralizes Covidien hernia mesh cases as MDL 3029 in D. Mass. under Judge Saris

April to June 2026: Pretrial rulings

Court rules on Rule 702 expert challenges and holds that Covidien must face the Patterson claims at trial

July 13 to Aug. 4, 2026: First trial

Patterson v. Covidien is tried to a jury, which returns an $88 million verdict for the plaintiffs

Sept. 4, 2026: Post-trial motions

Motions for judgment as a matter of law, a new trial, and to alter the judgment are filed

Jan. 11, 2027: Second trial

Stephen v. Covidien is set for a jury trial, with a final pretrial conference on Dec. 10, 2026

Mar. 29, 2027: ProGrip trial

Passmore v. Covidien is set as the first ProGrip bellwether

Before trial, the court worked through motions to exclude eleven expert witnesses under Rule 702. Judge Saris's April 28 opinion allowed Covidien's biomaterials expert to testify, and in June Law360 reported that the court ruled Covidien had to face the bellwether claims at trial.

What comes next in MDL 3029

At an August 19, 2026 status conference, Judge Saris set the post-trial motion date for Patterson, scheduled Stephen v. Covidien (No. 22-cv-11590) for trial on January 11, 2027, and set a tentative March 29, 2027 date for a ProGrip case. Her September 18 scheduling order for Stephen sets pretrial motions for October 2, 2026, motions in limine for November 13, and a final pretrial conference for December 10. On September 23, she picked Passmore v. Covidien as the ProGrip bellwether, noting it was the plaintiffs' turn to choose, and later set that trial for March 29, 2027. Mealey's also reported the January 2027 date.

No global settlement has been announced. Covidien is one of the last major hernia mesh litigations still active: Becton Dickinson agreed in 2024 to settle much of its Bard hernia mesh litigation, which involved about 38,000 claims, and Ethicon settled many Physiomesh claims. How Judge Saris rules on the post-trial motions, and how the Stephen jury responds in January, will shape whether talks begin.

Implications for pending inventories

Firms managing Covidien dockets can now audit case files against a real verdict. Patterson won on a warning theory tied to one product's collagen barrier, and his case was built on a documented chain from the 2017 implant to the 2020 revision surgery. Any settlement framework that follows is likely to weigh product identification, revision documentation, and complication severity. The ProGrip trial in March also means ProGrip files need the same level of product confirmation as Symbotex files.

Traditional Approach vs LlamaLab Solution

Traditional Approach

Missing Product ID
Operative notes lacking implant stickers or catalog numbers delay claim tiering
Incomplete Revision Chain
Gaps between implant and explant leave causation timelines vulnerable
Scattered Specialists
General surgery, GI, and imaging records reside across systems clients omit
Hidden & Unpredictable Costs
Per-page fees, rush charges, and surprise bills that blow up your budget

LlamaLab Solution

Reverse Provider Search
Uses insurance data to find implant hospitals, revision surgeons, and imaging clinics
Fast Record Retrieval
Records come back in 4 days on average, and 30 to 40% come back the same day
Recoverable Disbursement
Itemized per-case invoices flow through as recoverable case disbursements on settlement statements
Flat Transparent, Risk-free Pricing
1 flat fee covers all costs. Only pay full price for cases that authorize

Qualification profile

Strong Covidien mesh files document:

Implantation of a Covidien product (such as Symbotex, Parietex, or ProGrip)
Documented complications: adhesions, bowel obstruction, infection, chronic pain, or recurrence
Revision, explant, or subsequent abdominal surgery related to the mesh

Required medical records

Original hernia repair operative report and implant identification (stickers, lot, or catalog numbers)
Pre- and post-operative diagnostic imaging
Revision and explant operative notes with pathology reports
GI, pain management, and primary care records establishing ongoing treatment
Hospital billing records (UB-04) verifying product and procedure codes

Records come back in 4 days on average, and 30 to 40% come back the same day. LlamaLab's medical record retrieval for mass tort dockets uses insurance data to fill in treatment gaps clients don't always remember across implant facilities and revision surgeons. Invoices are itemized per case to flow through as recoverable case disbursements on settlement statements. Firms comparing vendors for multi-facility mesh claims can review how law firm medical record retrieval services differ on turnaround, provider discovery, and billing. For related settlement context, see LlamaLab's guide to Bard mesh settlement documentation tiers.

Next steps

Key Points

Essential takeaways from this article

Watch for Judge Saris's rulings on the Patterson post-trial motions filed September 4, 2026, and for any appeal that follows

Track the Stephen schedule: pretrial motions due October 2, motions in limine due November 13, final pretrial conference December 10, and trial January 11, 2027

Confirm the implanted product in every file, since the March 29, 2027 Passmore trial will test ProGrip claims

Review state statutes of limitations, noting that revision surgery dates often trigger relevant filing clocks

Summary

The Covidien MDL now has its first jury verdict: $88 million for the Pattersons, which Medtronic says it will challenge. With a second trial set for January 2027 and a ProGrip trial in March, firms that have complete implant-to-explant records in hand will be ready whether the next step is another trial or settlement talks.

Cover of The Medical Record Retrieval Playbook for PI and Mass Tort Firms

Preparing Covidien mesh files for the next trial?

Get the follow-up cadence for slow providers, a mass tort intake workflow, and a one-page retrieval checklist.

Get the playbookFree PDF, 16 pages

Building Covidien Mesh Cases?

Records come back in 4 days on average, and 30 to 40% come back the same day. LlamaLab retrieves operative reports, implant stickers, revision notes, and specialist records.

Start Case Retrieval See How It Works

Sources: Reuters (August 4, 2026), Patterson v. Covidien docket, D. Mass. No. 1:22-cv-10153, MDL 3029 docket, D. Mass. No. 1:22-md-03029, JPML pending MDL report (September 1, 2026), Medtronic Form 10-Q (filed September 3, 2026), GovInfo court opinion (April 28, 2026), MassDevice, Law360, Mealey's, MD+DI, AboutLawsuits, Drugwatch. Case counts current as of the JPML's September 1, 2026 report and Medtronic's August 5, 2026 disclosure.